Mylan Pharmaceuticals Private Limited — Bevacizumab Exporter Profile
Indian Pharmaceutical Exporter · #7 for Bevacizumab · $650.0K export value · DGFT Verified
Mylan Pharmaceuticals Private Limited is the #7 Indian exporter of Bevacizumab with $650.0K in export value and 13 verified shipments. Mylan Pharmaceuticals Private Limited holds a 1.4% market share in Bevacizumab exports across 5 countries. The company exports 2 pharmaceutical products worth $900.0K across 1 therapeutic categories.
Mylan Pharmaceuticals Private Limited — Bevacizumab Export Profile: Buyers & Destinations
Where Does Mylan Pharmaceuticals Private Limited Export Bevacizumab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOLDOVA,REPUBLIC OF | $112.4K | 4 | 33.5% |
| ZIMBABWE | $90.0K | 4 | 26.8% |
| KENYA | $83.0K | 2 | 24.8% |
| GAUTEMALA | $50.0K | 1 | 14.9% |
| BANGLADESH | $0 | 2 | 0.0% |
Mylan Pharmaceuticals Private Limited exports Bevacizumab to 5 countries. The largest destination is MOLDOVA,REPUBLIC OF accounting for 33.5% of Mylan Pharmaceuticals Private Limited's Bevacizumab shipments, followed by ZIMBABWE (26.8%) and KENYA (24.8%). These destinations reflect Mylan Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bevacizumab from Mylan Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DITA ESTFARM SRL | MOLDOVA,REPUBLIC OF | $112.4K | 4 |
| NEW AVAKASH INTERNATIONAL | ZIMBABWE | $90.0K | 4 |
| M/S. SURGILINKS LIMITED., | KENYA | $83.0K | 2 |
| M/S. AVIV FARMACEUTICA S.A., | GAUTEMALA | $50.0K | 1 |
| CONTACT PERSON:LUTFUR RAHMAN, | BANGLADESH | $0 | 2 |
Mylan Pharmaceuticals Private Limited supplies Bevacizumab to 5 buyers globally. The largest buyer is DITA ESTFARM SRL (MOLDOVA,REPUBLIC OF), followed by NEW AVAKASH INTERNATIONAL (ZIMBABWE) and M/S. SURGILINKS LIMITED., (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bevacizumab Export Value and How Much Does Mylan Pharmaceuticals Private Limited Contribute?
India exported $15.2M worth of Bevacizumab through 1,408 shipments from 196 suppliers to 100 countries, serving 346 buyers globally. Mylan Pharmaceuticals Private Limited contributes $650.0K to this total, accounting for 1.4% of India's Bevacizumab exports. Mylan Pharmaceuticals Private Limited ships Bevacizumab to 5 countries through 5 buyers.
What Is the Average Shipment Value for Mylan Pharmaceuticals Private Limited's Bevacizumab Exports?
Mylan Pharmaceuticals Private Limited's average Bevacizumab shipment value is $50.0K per consignment, based on 13 shipments totaling $650.0K. The largest destination is MOLDOVA,REPUBLIC OF (33.5% of Mylan Pharmaceuticals Private Limited's Bevacizumab exports).
How Does Mylan Pharmaceuticals Private Limited Compare to Other Indian Bevacizumab Exporters?
Mylan Pharmaceuticals Private Limited ranks #7 among 196 Indian Bevacizumab exporters with a 1.4% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($6.5M), BIOCON BIOLOGICS INDIA LIMITED ($2.3M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($2.1M). Mylan Pharmaceuticals Private Limited processed 13 shipments to 5 destination countries.
What Bevacizumab Formulations Does Mylan Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BEVACIZUMAB CSI 400MG/16ML 1 VL IN MY | $150.0K | 3 |
| BEVACIZUMAB CSI 100MG/4ML 1 VL IN MY | $95.4K | 4 |
| BEVACIZUMAB CSI 400MG 16ML 1 VL IN MY | $70.0K | 2 |
| BEVACIZUMAB CSI 100MG 4ML 1 VL IN MY | $20.0K | 2 |
| (ABEVMY 400 MG(BEVACIZUMAB INJECTION(R-D | $0 | 1 |
| (ABEVMY 100 MG(BEVACIZUMAB INJECTION(R-D | $0 | 1 |
Mylan Pharmaceuticals Private Limited exports 6 distinct Bevacizumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BEVACIZUMAB CSI 400MG/16ML 1 VL IN MY with 3 shipments worth $150.0K.
How Does Mylan Pharmaceuticals Private Limited Compare to Nearest Bevacizumab Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | ZYDUS LIFESCIENCES LIMITED | $1.1M | 21 | 4 | $50.0K |
| 3 | DR REDDY S LABORATORIES LTD | $700.0K | 14 | 1 | $50.0K |
| 7 | MYLAN PHARMACEUTICALS PRIVATE LIMITED ★ | $650.0K | 13 | 5 | $50.0K |
| 6 | DR REDDYS LABORATORIES LIMITED | $500.0K | 10 | 4 | $50.0K |
| 8 | DR.REDDY'S LABORATORIES LIMITED | $500.0K | 10 | 4 | $50.0K |
Mylan Pharmaceuticals Private Limited ranks #7 among 196 Indian Bevacizumab exporters. Average shipment value of $50.0K compared to the market average of $77.5K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and DR REDDY S LABORATORIES LTD.
Which Indian Ports Ship Bevacizumab Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 345 | 24.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 327 | 23.2% |
| HYDERABAD ACC (INHYD4) | 132 | 9.4% |
| Bombay Air | 89 | 6.3% |
| DELHI AIR CARGO ACC (INDEL4) | 48 | 3.4% |
| DELHI AIR | 47 | 3.3% |
| HYDERABAD AIR | 36 | 2.6% |
| AHEMDABAD AIR | 32 | 2.3% |
What Other Advanced Oncology Products Does Mylan Pharmaceuticals Private Limited Export?
Mylan Pharmaceuticals Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Mylan Pharmaceuticals Private Limited
Mylan Pharmaceuticals Private Limited exports 2 products worth $900.0K. Beyond Bevacizumab, top products include Trastuzumab. View the complete Mylan Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bevacizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bevacizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Mylan Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 13 individual customs records matching Mylan Pharmaceuticals Private Limited exporting Bevacizumab, covering 6 formulations to 5 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 346+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bevacizumab Export Data from Mylan Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Mylan Pharmaceuticals Private Limited's Bevacizumab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Mylan Pharmaceuticals Private Limited
Full Company Profile →
2 products · $900.0K total trade · 1 categories
Bevacizumab Stats
Company Overview
Top Products by Mylan Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Mylan Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bevacizumab. For current shipment-level data, contact TransData Nexus.